Methylphenidate and Autism Ranking: Mildly Hazardous Strong positive evidence

Ongoing Research

  • Massachusetts General Hospital is running a study to determine whether methylphenidate hydrochloride extended release liquid formulation is safe and effective in the treatment of attention-deficit/hyperactivity disorder (ADHD) in high-functioning adults with autism spectrum disorders (ASD). Clinical Trials Gov Ref: NCT02096952. For more details, please see Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD Full Item(Open in New Window)
  • Yale University is running a study to determine whether guanfacine by itself or in combination with methylphenidate is helpful for treating hyperactivity in children and adolescents with a pervasive developmental disorders (PDDs). Clinical Trials Gov Ref: NCT01238575. For more details, please see Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder Full Item(Open in New Window)
24 Dec 2018
Last Review
01 Dec 2018
Next Review
01 Dec 2021